menu ☰
menu ˟

[Department of Error] Department of Error

22 Mar 2014

Mullard A. FDA's rejection of alemtuzumab divides neurologists. Lancet 2014; 383: 859—In this World Report (March 8), Dennis Bourdette's surname was spelt incorrectly. This correction has been made to the online version as of March 21, 2014.

22 March 2014

Click here to view the full article which appeared in The Lancet